Mỹ khuyến nghị sử dụng vắcxin của Johnson&Johnson cho người trên 18
Ngày 28/2, các chuyên gia tư vấn của Ủy ban tư vấn về thực hiện tiêm chủng thuộc Trung tâm Kiểm soát và Phòng ngừa Dịch bệnh Mỹ (CDC) đã bỏ phiếu ủng hộ khuyến nghị sử dụng vắcxin ngừa COVID-19 của hãng Johnson & Johnson cho người dân Mỹ từ 18 tuổi trở lên.
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
Bình luận
Xin vui lòng gõ tiếng Việt có dấu